Bio-Rad Laboratories Inc. Class A (BIO)

$246.34

up-down-arrow $2.83 (1.16%)

As on 14-May-2026 10:47EDT

Market cap

info icon

$6,524 Mln

Revenue (TTM)

info icon

$2,590 Mln

P/E Ratio

info icon

40.6

P/B Ratio

info icon

1

Div. Yield

info icon

0 %

Bio-Rad Laboratories Inc. Class A (BIO) Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

Stock Range

Today’s Range

Low: 243.43 High: 249.35

52 Week Range

Low: 211.43 High: 343.12

Liquidityliquidity High

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $696 Mln

  • ROEROE information

    0 %

  • ROCEROCE information

    9 %

  • Industry P/EIndustry P/E information

    44.07

  • EV/EBITDAEV/EBITDA information

    15.1

  • Debt to EquityDebt to Equity information

    0.1

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $6.1

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    21,700,560

10 Years Aggregate

CFO

$3,324.47 Mln

EBITDA

$4,405.61 Mln

Net Profit

$6,268.10 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Bio-Rad Laboratories Inc. Class A (BIO)
-18.7 -14.5 -4.0 -2.7 -12.9 -16.1 5.6
BSE Sensex
-11.0 -1.9 -8.7 -7.1 6.7 9.1 11.5
S&P Midcap 400
9.6 4.1 3.8 20.3 14.7 6.9 9.7
As on 14-May-2026
Company
2025
2024
2023
2022
2021
2020
2019
Bio-Rad Laboratories Inc. Class A (BIO)
-7.8 1.7 -23.2 -44.3 29.6 57.5 59.3
S&P Midcap 400
5.9 12.1 14.4 -14.5 23.2 11.8 24.1
BSE Sensex
9.1 8.1 18.7 4.4 22.0 15.8 14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

*All values are in ($ Mln)

*All values are in ($ Mln)

*All values are in ($ Mln)

Key Ratios

View Details

5Y Avg -- 3Y Avg -- TTM --

P/E Ratio

--

--Min --Median --Max

P/B Ratio

--

--Min --Median --Max

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

Peers

View Details
Company
Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Bio-Rad Laboratories Inc. Class A (BIO)
246.3 6,524.2 2,589.9 168.8 21.4 2.5 40.6 1.0
84.8 143,804.1 45,134.0 6,276.0 15.4 12.2 23.1 2.8
17.7 9,053.7 11,320.0 -1,098.0 -2.0 -16.5 -- 1.5
76.2 10,408.9 3,100.6 586.7 14.2 12.9 17.9 2.2
71.4 7,859.1 13,384.0 395.0 5.2 11.2 20.8 2.5
150.6 10,678.5 2,900.9 302.8 15.9 22.5 35.9 8.2
433.6 148,769.7 10,582.1 2,979.1 22.4 17.2 51 9.1
25.7 25,447.4 17,706.2 972.5 8.7 8.8 22.7 1.9
131.5 5,742.7 2,811.2 -1,008.8 -7.9 -29.2 2162 1.9
453.5 168,195.9 45,197.0 6,859.0 19.2 13.3 24.9 3.3

Shareholding Pattern

View Details
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About Bio-Rad Laboratories Inc. Class A (BIO)

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science...  and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California. Address: 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547  Read more

  • Chairman, CEO, President & Principal Financial Officer

    Mr. Norman D. Schwartz

  • Chairman, CEO & President

    Mr. Norman D. Schwartz

  • Headquarters

    Hercules, CA

  • Website

    https://www.bio-rad.com

Edit peer-selector-edit

FAQs for Bio-Rad Laboratories Inc. Class A (BIO)

The share price of Bio-Rad Laboratories Inc Class A (BIO) is $246.34 (NYSE) as of 14-May-2026 10:47 EDT. Bio-Rad Laboratories Inc Class A (BIO) has given a return of -12.88% in the last 3 years.

The P/E ratio of Bio-Rad Laboratories Inc Class A (BIO) is 40.63 times as on 12-May-2026, a 8 discount to its peers’ median range of 44.07 times.
The P/B ratio of Bio-Rad Laboratories Inc Class A (BIO) is 0.99 times as on 12-May-2026, a 66 discount to its peers’ median range of 2.89 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
10.77
1.10
2024
-4.99
1.40
2023
-14.60
1.06
2022
-3.45
1.30
2021
5.31
1.65

The 52-week high and low of Bio-Rad Laboratories Inc Class A (BIO) are Rs 343.12 and Rs 211.43 as of 14-May-2026.

Bio-Rad Laboratories Inc Class A (BIO) has a market capitalisation of $ 6,524 Mln as on 12-May-2026. As per SEBI classification, it is a Mid Cap company.

Before investing in Bio-Rad Laboratories Inc Class A (BIO), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.